17 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Tanshinones as selective and slow-binding inhibitors for SARS-CoV cysteine proteases.
Korea Research Institute of Bioscience and Biotechnology
Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters.
University of Alberta
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China.
Qufu Normal University
Novel dithiocarbamates selectively inhibit 3CL protease of SARS-CoV-2 and other coronaviruses.
Univ. Lille
Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective.
University of Siena
Isatin compounds as noncovalent SARS coronavirus 3C-like protease inhibitors.
Peking University
Design and synthesis of peptidomimetic severe acute respiratory syndrome chymotrypsin-like protease inhibitors.
Purdue University
Synthesis and evaluation of isatin derivatives as effective SARS coronavirus 3CL protease inhibitors.
Development Center For Biotechnology
Two Binding Sites of SARS-CoV-2 Macrodomain 3 Probed by Oxaprozin and Meclomen.
University of Science and Technology of China
MACROCYCLIC PEPTIDOMIMETIC PROTEASE INHIBITOR AND USE THEREOF
Tencent Technology (Shenzhen)
Protacs based on VHL ligand targeting coronavirus 3CL protease and preparation method and application thereof
Shaanxi Panlong Pharmaceutical
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
University of Bonn
An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL Protease Inhibitors: Peptidomimetics and Small Molecule Chemotherapy.
University of Bonn
Screening of drugs by FRET analysis identifies inhibitors of SARS-CoV 3CL protease.
National Taiwan University
Phenolic phytochemical displaying SARS-CoV papain-like protease inhibition from the seeds of Psoralea corylifolia.
Gyeongsang National University